News
Those natural essential oils you love in your skincare? More than 90% of a plant is typically discarded during the oil ...
The quiet rise of K18—a premium haircare brand with a scientific soul—offers a textbook case of what modern consumers want, and what luxury brands must now deliver. Not louder claims. Not flashier ...
Two former FDA leaders look at Commissioner Marty Makary’s early stumbles — and lay out a list of priorities to protect both ...
Image source: Getty Images. There are even different regulatory paths for biotech and pharma products in the U.S. Companies that develop therapies made from living organisms must file a Biologics ...
Hosted on MSN18d
Opinion: America can’t afford to fall behind China in the race for biotech dominanceEarlier this week, the congressionally-mandated National Security Commission on Emerging Biotechnology released its major report, titled “Charting the Future of Biotechnology.” The bipartisan ...
The Fund seeks investment results that correspond, before fees and expenses, to the price and yield performance of the LifeSci Biotechnology Products Index. The Index seeks to track the ...
4d
Zacks Investment Research on MSNIs First Trust NYSE Arca Biotechnology ETF (FBT) a Strong ETF Right Now?Designed to provide broad exposure to the Health Care ETFs category of the market, the First Trust NYSE Arca Biotechnology ETF (FBT) is a smart beta exchange traded fund launched on 06/19/2006. What ...
Vir Biotechnology, Inc.’s VIR share price has surged by 5.82%, which has investors questioning if this is right time to sell.
US tech stocks led the S&P and Nasdaq higher on Friday after Google parent Alphabet reported strong earnings results and hopes of trade deals grew. - The market expects a widening gap between ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results